FreeTrials & Tribulations Learning to “talk less and smile more” while designing a COE strategy worthy of trust April 27, 2018Vol.44 No.17By Erin N. Kobetz
Conversation with The Cancer LetterFree Peter Tunney: How the largest art movement in history can help reduce cancer disparities April 27, 2018Vol.44 No.17By Paul Goldberg
Free Miami’s Sylvester uses cool art to bridge disparities—and meet NCI’s new requirement April 27, 2018Vol.44 No.17By Paul Goldberg
Free Piantadosi leaves Cedars-Sinai for Alliance and Harvard April 20, 2018Vol.44 No.16By Paul Goldberg
Free Sharpless adds $100 million to NCI’s RPG pool,R01s for young investigators boosted by 25% April 20, 2018Vol.44 No.16By Matthew Bin Han Ong
FreeTrials & Tribulations Sales Revenues at the Potential Expense of Patient Safety:The Example of You&i April 13, 2018Vol.44 No.15By Mark J. Ratain, Lisa S. Chen, Allen S. Lichter, R. Donald Harvey, Sonali M. Smith, Leonard B. Saltz, William G. Wierda, Varsha V. Gandhi and Michael J. Keating
Whistleblower suit claims McKesson repackaged, sold cancer drug “overfill” April 13, 2018Vol.44 No.15By Paul Goldberg
FreeTrials & Tribulations The importance of staging lung cancer consistently and correctly worldwide April 06, 2018Vol.44 No.14By Fred R. Hirsch
